Glimepiride, a new once-daily sulfonylurea. A double-blind placebo-controlled study of NIDDM patients. Glimepiride Study Group.
Autor: | Rosenstock J, Samols E, Muchmore DB, Schneider J, Glimepirade Study Group, Rosenstock, J, Samols, E, Muchmore, D B, Schneider, J |
---|---|
Zdroj: | Diabetes Care; Nov1996, Vol. 19 Issue 11, p1194-1199, 6p |
Databáze: | Complementary Index |
Externí odkaz: |